Latest News

Clieck HERE to read our latest Open Briefing interview with Andrew McLellan https://www.asx.com.au/asxpdf/20190429/pdf/444lr6fnh6n4gh.pdf

You will always find the latest presentation and videos under the Company Overview page Download the March 2019 Broker Presentation Watch the Corpoporate Video updated this week: 26th of March 2019

In this Open Briefing®, Andrew discusses: • Four new OEM proposals under consideration • Growing market enquiries and successful trade shows including ISBER and SLAS • Six months trading results, period ended 31 December 2018 • Changing revenue mix to ongoing consumables sales • Increasing production and delivery under US$11.9m Labcon contract Open Briefing interview…

The “Pulmonary Biobank Consortium, CIBER of Respiratory Diseases (CIBERES) – ISCIII (Madrid), Institut d’Investigació Sanitària de les Illes Balears (IdISBA) – Hospital Universitari Son Espases, Mallorca, Spanish Biobank Network” recently presented a scientific poster about Bluechiip technology in the International Society of Biobanks and Environmental Repositories (ISBER) Symposium this February 2019 in Berlin. See CIBERES…

In this Open Briefing, Andrew discusses: Labcon’s official release and marketing of Bluechiip enabled product Accelerating sales and production scaling progress Reader production status and approvals Partner progress and cash position Download the full document here: https://www.asx.com.au/asxpdf/20190130/pdf/4425m31s7m9cnn.pdf

Download the presentation shown during the past AGM on the 26th of November 2018 https://www.asx.com.au/asxpdf/20181126/pdf/440mb0vpc9v670.pdf

Notice is given that the Annual General Meeting of the members of Bluechiip Limited will be held on Monday 26 of Nov 2018 at 10am. Location: Level 16, 333 Collins St, Melbourne, Vic, 3000 (offices of Phillips Ormonde Fitzpatrick). Download the ASX announcement in full here: https://www.asx.com.au/asxpdf/20181024/pdf/43zl1vfd331cpv.pdf

Watch the video: https://youtu.be/q64uGtuUwY4

In this Open Briefing, Andrew discusses: Recent #7.5M capital raise and the updated $15.9M over 3 yr Labcon agreement Recent customer activity and finalisation and product portfolio Recent 4C and cashflow forecast Partner and opportunity pipeline Read the full announcement here: https://www.asx.com.au/asxpdf/20181018/pdf/43zcy4f8442yrg.pdf

Read the full announcement here: https://www.asx.com.au/asxpdf/20181018/pdf/43zcy1zcj8cw0r.pdf